Item 16. Form 10-K Summary

3K characters. Original on sec.gov · Markdown

Item 16. Form 10-K Summary

Registrants may voluntarily include a summary of information required by Form 10-K under this Item 16. The Company has not elected to include such summary information.

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.


	Medtronic plc

Dated: June 20, 2025	By:	/s/ Geoffrey S. Martha
		Geoffrey S. Martha
		Chairman and Chief Executive Officer

Pursuant to the requirements of the Securities Exchange Act of 1934, the report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.


	Medtronic plc

Dated: June 20, 2025	By:	/s/ Geoffrey S. Martha
		Geoffrey S. Martha
		Chairman and Chief Executive Officer
		(Principal Executive Officer)


Dated: June 20, 2025	By:	/s/ Thierry Piéton
		Thierry Piéton
		Executive Vice President and Chief Financial Officer
		(Principal Financial Officer)

Dated: June 20, 2025	By:	/s/ Denise L. Blomquist
		Denise L. Blomquist
		Vice President, Global Controller and Chief Accounting Officer
		(Principal Accounting Officer)


	Directors

		Craig Arnold*
		Scott C. Donnelly*
		Lidia Fonseca*
		Andrea J. Goldsmith, Ph.D.*
		Randall J. Hogan*
		Gregory P. Lewis*
		Kevin E. Lofton*
		Geoffrey S. Martha
		Elizabeth G. Nabel, M.D.*
		Kendall J. Powell*

*Ivan K. Fong, by signing his name hereto, does hereby sign this document on behalf of each of the above named directors of the registrant pursuant to powers of attorney duly executed by such persons.


Dated: June 20, 2025			By:			/s/ Ivan K. Fong
						Ivan K. Fong

Previous: Item 15. Exhibits and Financial Statement Schedules